Pre-Eclampsia-Associated Reduction in Placental Growth Factor Impaired Beta Cell Proliferation Through PI3k...

Area of Science:

• Endocrinology
• Reproductive Biology
• Cell Biology

Background:

• Reduced placental growth factor (PLGF) is linked to preeclampsia (PE) and gestational diabetes mellitus (GDM).
• Impaired gestational beta-cell growth, potentially due to PE-associated PLGF reduction, may lead to GDM.
• This study investigates the mechanisms by which PLGF influences beta-cell growth.

Purpose of the Study:

• To elucidate the mechanisms underlying PLGF's role in gestational beta-cell proliferation.
• To understand how PLGF interacts with islet endothelial cells to affect beta-cell function.
• To explore the signaling pathways involved in PLGF-mediated beta-cell growth.

Main Methods:

• Co-culture of primary mouse beta cells with mouse islet endothelial cells (MS1) ± PLGF.
• Culture of beta cells in conditioned media from PLGF-treated MS1 cells.
• Analysis of beta-cell proliferation (BrdU incorporation), cell number (MTT assay), and cell-cycle regulators (Western blot) with pathway inhibitors.

Main Results:

• PLGF alone did not induce beta-cell proliferation, but significantly augmented it when co-cultured with MS1 cells.
• Conditioned media from PLGF-treated MS1 cells induced beta-cell proliferation via PI3k/Akt signaling, not ERK/MAPK or JNK.
• PLGF-induced proliferation involved decreased p21/p27 and increased CDK4/CyclinD1 in beta cells.

Conclusions:

• Gestational PLGF targets islet endothelial cells, releasing factors that activate PI3k/Akt signaling in beta cells, thereby increasing proliferation.
• Reduced PLGF in PE impairs these endothelial-beta cell interactions, contributing to GDM development.
• These findings highlight a novel mechanism linking PLGF, endothelial cells, and beta-cell function in pregnancy.